Sign in to fuzzto save your conversations, follow your research and come back anytime.
Fairchem Organics
FAIRCHEMOR
NSE
BSE
NSEBSESectorChemicals
661.10
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Fairchem Organics delivers a robust recovery in Q1 FY27, with revenue and PAT surging as margins expand significantly.
Revenue surged from ₹1,001 Cr in Q3 FY26 to ₹1,761 Cr in Q1 FY27, reflecting strong demand recovery.
Finance cost rose from ₹10 Cr in Q3 FY26 to ₹18 Cr in Q1 FY27, increasing debt servicing pressure.
EBITDA margin expanded from 4.20% in Q3 FY26 to 10.16% in Q1 FY27, confirming improved pricing power.
Average trading volume declined from 26.0 in Q3 FY26 to 18.7 in Q1 FY27, indicating weakening liquidity.
PAT jumped from ₹6 Cr in Q3 FY26 to ₹100 Cr in Q1 FY27, signaling a robust profitability turnaround.
AIF shareholding dropped from 6% in Q1 FY26 to 2.02% in Q1 FY27, signaling reduced institutional interest.
Promoter shareholding increased from 61% in Q3 FY26 to 63.26% in Q1 FY27, showing strong insider confidence.
